Nuclear translocation of beta-catenin in colorectal cancer
2000

Nuclear Translocation of Beta-Catenin in Colorectal Cancer

Sample size: 75 publication Evidence: moderate

Author Information

Author(s): Kobayashi M, Honma T, Matsuda Y, Suzuki Y, Narisawa R, Ajioka Y, Asakura H

Primary Institution: Niigata University School of Medicine

Hypothesis

The study investigates the role of beta-catenin translocation in colorectal cancer development.

Conclusion

Nuclear translocation of beta-catenin is involved in the development of intramucosal cancer, while cytoplasmic accumulation occurs in adenomas.

Supporting Evidence

  • Nuclear over-expression of beta-catenin was observed in 35% of intramucosal cancers and 42% of invasive cancers.
  • No nuclear expression of beta-catenin was seen in any adenomas from sporadic or FAP cases.
  • Cytoplasmic beta-catenin in adenomas was significantly higher than that of normal mucosa.

Takeaway

This study found that a protein called beta-catenin moves into the nucleus in some cancers, which might help those cancers grow, but it doesn't do the same in benign growths.

Methodology

The study used immunohistochemistry to analyze beta-catenin localization in colorectal adenomas and cancers.

Participant Demographics

The study included sporadic colorectal adenomas, intramucosal cancers, and invasive cancers, as well as familial adenomatous polyposis cases.

Digital Object Identifier (DOI)

10.1054/bjoc.1999.1112

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication